Meuleners Biostat: what changed
Meuleners Biostat
Largest movements
- Cash +€43,632
up €43,632 (+108%), from €40,264 to €83,897
mainly Net result for the year (+€58,178) and Tax, wage and social debts (+€11,272)
- Current investments +€20,000
new in 2025: €20,000
- Receivables within one year +€4,865
up €4,865 (+24.0%), from €20,238 to €25,102
- Reserves +€58,178
up €58,178 (+130%), from €44,600 to €102,778
- Tax, wage and social debts +€11,272
up €11,272 (+178%), from €6,315 to €17,587
- Gross operating margin +€18,721
up €18,721 (+30.2%), from €62,084 to €80,805
- Taxes +€5,072
up €5,072 (+29.3%), from €17,283 to €22,354
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €60,502 | €128,999 | +€68,497 | +113% |
| Current assets | 29/58 | €60,502 | €128,999 | +€68,497 | +113% |
| Amounts receivable within one year | 40/41 | €20,238 | €25,102 | +€4,865 | +24.0% |
| Trade receivables | 40 | €20,238 | €25,102 | +€4,865 | +24.0% |
| Current investments | 50/53 | - | €20,000 | +€20,000 | |
| Cash at bank and in hand | 54/58 | €40,264 | €83,897 | +€43,632 | +108% |
| Total equity and liabilities | 10/49 | €60,502 | €128,999 | +€68,497 | +113% |
| Equity | 10/15 | €49,635 | €107,813 | +€58,178 | +117% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Contributions outside capital | 11 | €5,000 | - | -€5,000 | |
| Other | 1109/19 | €5,000 | - | -€5,000 | |
| Reserves | 13 | €44,600 | €102,778 | +€58,178 | +130% |
| Distributable reserves | 133 | €44,600 | €102,778 | +€58,178 | +130% |
| Profit (loss) carried forward | 14 | €35 | €35 | = | 0.0% |
| Amounts payable | 17/49 | €10,867 | €21,186 | +€10,320 | +95.0% |
| Amounts payable within one year | 42/48 | €10,867 | €21,186 | +€10,320 | +95.0% |
| Trade debts | 44 | €1,327 | €375 | -€952 | -71.7% |
| Suppliers | 440/4 | €1,327 | €375 | -€952 | -71.7% |
| Taxes, remuneration and social security | 45 | €6,315 | €17,587 | +€11,272 | +178% |
| Taxes | 450/3 | €6,315 | €17,587 | +€11,272 | +178% |
| Other amounts payable | 47/48 | €3,224 | €3,224 | = | 0.0% |
| Other operating charges | 640/8 | €106 | €195 | +€90 | +84.8% |
| Gross operating margin | 9900 | €62,084 | €80,805 | +€18,721 | +30.2% |
| Operating profit (loss) | 9901 | €61,979 | €80,610 | +€18,632 | +30.1% |
| Financial charges | 65/66B | €61 | €78 | +€17 | +28.0% |
| Recurring financial charges | 65 | €61 | €78 | +€17 | +28.0% |
| Profit (loss) for the period before taxes | 9903 | €61,918 | €80,532 | +€18,614 | +30.1% |
| Income taxes | 67/77 | €17,283 | €22,354 | +€5,072 | +29.3% |
| Profit (loss) for the period | 9904 | €44,635 | €58,178 | +€13,543 | +30.3% |
| Profit (loss) for the period to be appropriated | 9905 | €44,635 | €58,178 | +€13,543 | +30.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.